Harry Fisher – Project Manager – Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Copyright 2023 – Finance News Network
Source: Finance News Network
02 June 2025 - Tariff shocks, central bank inertia, defensive positioning.
Read More21 Feb 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses progress towards construction of a lithium refinery.
Read More06 Jul 2023 - Tamboran Resources Limited (ASX:TBN) Managing Director and CEO Joel Riddle discusses the company's recent capital raise, the drilling timeline, and agreements with APA Group, Clean Energy Fuels Australia, BP and Shell.
Read More18 Dec 2019 - Oventus Medical Limited (ASX:OVN) Managing Director and CEO, Dr Chris Hart talks about the company's North American sales process via its lab in lab model and how this improves patient outcomes.
Read More09 Sep 2020 - BrainChip Holdings Limited (ASX:BRN) President & CEO Louis DiNardo provides an update on collaboration and partnerships for the company's AI chip, Akida.
Read More05 Feb 2024 - Chariot Corporation (ASX:CC9) Managing Director Shanthar Pathmanathan and Geological Consultant Dr Edward Max Baker discuss the significance of the company's latest drill results.
Read More08 Jul 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO Stefano Marani talks about the company's high concentration of helium from Phase 1 drill results at its Virginia Gas Field in the Karoo Basin, South Africa.
Read More16 Aug 2021 - BluGlass Limited (ASX:BLG) Executive Chair, James Walker and Chief Technology and Operations Officer, Dr Ian Mann discuss the company’s world-first demonstration of working tunnel junction laser diodes created using remote plasma chemical vapour deposition (RPCVD) technology.
Read More04 Sep 2023 - Glen Diemar, Managing Director of Australian Gold and Copper Limited (ASX:AGC), provides an update on the company, discussing drill targets, plans and outlook.
Read More31 Oct 2023 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company's drug candidates, highlighting promising data from the 2023 ESMO Congress.
Read More
